Adverse Outcome Pathway on Protein Alkylation Leading to Liver Fibrosis

Brigitte Landesmann
Additional contact information
Brigitte Landesmann: European Commission

No 2, OECD Series on Adverse Outcome Pathways from OECD Publishing

Abstract: Liver fibrosis is an important human health issue associated with chemical exposure. It is a typical result of chronic toxic injury and one of the considered endpoints for regulatory purposes. This AOP describes the linkage between hepatic injury caused by protein alkylation and the formation of liver fibrosis. Fibrogenesis is a long-term and complex process for which an adequate cell model is not available and an in vitro evaluation of fibrogenic potential is therefore not feasible yet. This systematic and coherent display of currently available mechanistic-toxicological information can serve as a knowledge-based repository for identification/selection/development of in vitro methods suitable for measuring key events and their relationships along the AOP and to facilitate the use of alternative data for regulatory purposes. Identified uncertainties and knowledge gaps can indicate priorities for future research.

Keywords: hepatotoxicity; liver fibrosis; protein alkylation (search for similar items in EconPapers)
Date: 2016-08-04
New Economics Papers: this item is included in nep-cse
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/5jlsvwl6g7r5-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:envaad:2-en

Access Statistics for this paper

More papers in OECD Series on Adverse Outcome Pathways from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().